Intrance Medical Systems Inc signs LOI purchase commitment for clinical trials with Parkinson's diseases patients

Contributed by: PR Newswire

Tags

Tridentify-AB

More Like This

Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion App to aid in the treatment of Parkinson's Disease

PR Newswire associated0

Loftware and Signant Health Announce Availability of Integrated Clinical Supplies Labeling Solution

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease

Neoclease receives Merck’s North American Advance Biotech Grant.

Merck Announces Neoclease as Winner of 2025 North American Advance Biotech Grant

Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey

Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial

ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense